Trails Edge Capital Partners, LP
35 holdingsFiling period: 2026-06-30Current AUM: $581.2Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | LBRX | LB Pharmaceuticals Inc | 1.52M | $49.4M | $60.5M | 10.40% | +203.7K | 2026-06-30 |
| 2 | NRIX | Nurix Therapeutics Inc | 1.57M | $38.2M | $42.2M | 7.25% | -170,000 | 2026-06-30 |
| 3 | IMCR | Immunocore Hldgs PLC | 1.06M | $33.8M | $32.4M | 5.58% | +380.6K | 2026-06-30 |
| 4 | TRAX | First Tracks Biotherapeutics | 1.51M | $30.5M | $68.2M | 11.74% | -- | 2026-06-30 |
| 5 | FDMT | 4D Molecular Therapeutics in | 2.23M | $29.6M | $26.5M | 4.56% | +925.0K | 2026-06-30 |
| 6 | BMRN | Biomarin Pharmaceutical Inc | 512.0K | $29.3M | $30.0M | 5.15% | -- | 2026-06-30 |
| 7 | DSGN | Design Therapeutics Inc | 2.00M | $29.0M | $21.4M | 3.68% | +1.15M | 2026-06-30 |
| 8 | XENE | Xenon Pharmaceuticals Inc | 440.0K | $26.6M | $16.5M | 2.83% | -200,000 | 2026-06-30 |
| 9 | MIRM | Mirum Pharmaceuticals Inc | 223.3K | $26.1M | $19.0M | 3.27% | -110,000 | 2026-06-30 |
| 10 | INSM | Insmed Inc | 230.3K | $24.6M | $25.9M | 4.46% | -- | 2026-06-30 |
| 11 | CYTK | Cytokinetics Inc | 288.1K | $24.5M | $18.1M | 3.12% | -11,911 | 2026-06-30 |
| 12 | SNDX | Syndax Pharmaceuticals Inc | 1.11M | $24.3M | $15.2M | 2.61% | +408.2K | 2026-06-30 |
| 13 | NGNE | Neurogene Inc | 714.9K | $22.5M | $19.7M | 3.39% | -67,902 | 2026-06-30 |
| 14 | KLRA | Kailera Therapeutics Inc | 984.8K | $21.7M | $12.7M | 2.18% | -- | 2026-06-30 |
| 15 | RVMD | Revolution Medicines Inc | 115.8K | $21.7M | $22.1M | 3.81% | -129,250 | 2026-06-30 |
| 16 | IKT | Inhibikase Therapeutics Inc | 9.05M | $18.4M | $14.0M | 2.41% | +994.0K | 2026-06-30 |
| 17 | INCY | Incyte Corp | 155.0K | $17.6M | $18.7M | 3.21% | -- | 2026-06-30 |
| 18 | AVTX | Avalo Therapeutics Inc | 891.9K | $16.5M | $6.4M | 1.10% | -- | 2026-06-30 |
| 19 | MLTX | Moonlake Immunotherapeutics | 750.0K | $14.6M | $8.8M | 1.52% | -- | 2026-06-30 |
| 20 | SNSE | Faeth Therapeutics Inc | 515.3K | $12.9M | $12.9M | 2.22% | +390.3K | 2026-06-30 |
| 21 | XFOR | X4 Pharmaceuticals Inc | 2.57M | $12.0M | $8.6M | 1.48% | -- | 2026-06-30 |
| 22 | IRD | Opus Genetics Inc | 2.74M | $11.3M | $10.1M | 1.73% | +2.24M | 2026-06-30 |
| 23 | — | Sol-Gel Technologies Ltd | 139.4K | $10.3M | $10.3M | 1.78% | +53.9K | 2026-06-30 |
| 24 | AURA | Aura Biosciences Inc | 1.44M | $10.2M | $8.9M | 1.52% | -- | 2026-06-30 |
| 25 | IPSC | Century Therapeutics Inc | 4.13M | $10.1M | $6.1M | 1.05% | +1.68M | 2026-06-30 |
← Scroll →
Page 1 of 2